Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Thromb Haemost ; 13(6): 1004-9, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25845618

ABSTRACT

BACKGROUND: General practitioners can safely exclude pulmonary embolism (PE) by using the Wells PE rule combined with D-dimer testing. OBJECTIVE: To compare the accuracy of a strategy using the Wells rule combined with either a qualitative point-of-care (POC) D-dimer test performed in primary care or a quantitative laboratory-based D-dimer test. METHODS: We used data from a prospective cohort study including 598 adults suspected of PE in primary care in the Netherlands. General practitioners scored the Wells rule and carried out a qualitative POC test. All patients were referred to hospital for reference testing. We obtained quantitative D-dimer test results as performed in hospital laboratories. The primary outcome was the prevalence of venous thromboembolism in low-risk patients. RESULTS: Prevalence of PE was 12.2%. POC D-dimer test results were available in 582 patients (97%). Quantitative test results were available in 401 patients (67%). We imputed results in 197 patients. The quantitative test and POC test missed one (0.4%) and four patients (1.5%), respectively, with a negative strategy (Wells ≤ 4 points and D-dimer test negative) (P = 0.20). The POC test could exclude 23 more patients (4%) (P = 0.05). The sensitivity and specificity of the Wells rule combined with a POC test were 94.5% and 51.0% and, combined with a quantitative test, 98.6% and 47.2%, respectively. CONCLUSIONS: Combined with the Wells PE rule, both tests are safe to use in excluding PE. The quantitative test seemed to be safer than the POC test, albeit not statistically significant. The specificity of the POC test was higher, resulting in more patients in whom PE could be excluded.


Subject(s)
Decision Support Techniques , Fibrin Fibrinogen Degradation Products/analysis , Point-of-Care Systems , Primary Health Care/methods , Pulmonary Embolism/blood , Pulmonary Embolism/diagnosis , Venous Thromboembolism/blood , Venous Thromboembolism/diagnosis , Biomarkers/blood , Female , General Practitioners , Humans , Male , Middle Aged , Netherlands/epidemiology , Predictive Value of Tests , Prevalence , Prospective Studies , Pulmonary Embolism/epidemiology , Reproducibility of Results , Risk Factors , Venous Thromboembolism/epidemiology
2.
J Thromb Haemost ; 8(11): 2412-7, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20735722

ABSTRACT

INTRODUCTION: Data regarding outpatient treatment of pulmonary embolism (PE) is scarce. This study evaluates the safety of outpatient management of acute PE. METHODS: This is a retrospective cohort study of consecutive patients presenting at the Ottawa Hospital with acute PE diagnosed between 1 January 2007 and 31 December 2008. PE was defined as an arterial filling defect on CTPA or a high probability V/Q scan. Patients were managed as outpatients if they were hemodynamically stable, did not require supplemental oxygenation and did not have contraindications to low-molecular-weight heparin therapy. RESULTS: In this cohort of 473 patients with acute PE, 260 (55.0%) were treated as outpatients and 213 (45.0%) were admitted to the hospital. The majority of the patients were admitted because of severe comorbidities (45.5%) or hypoxia (22.1%). No outpatient died of fatal PE during the 3-month follow-up period. At the end of follow-up, the overall mortality was 5.0% (95% CI, 2.7-8.4%). The rates of recurrent venous thromboembolism (VTE) in outpatients were 0.4% (95% CI, 0.0-2.1%) and 3.8% (95% CI, 1.9-7.0%) within 14 days and 3 months, respectively. The rates of major bleeding episodes were 0% (95% CI, 0-1.4%) and 1.5% (95% CI, 0.4-3.9%) within 14 days and 3 months, respectively. Four (1.5%) outpatients were admitted to the hospital within 14 days. CONCLUSIONS: A majority of patients with acute PE can be managed as outpatients with a low risk of mortality, recurrent VTE and major bleeding episodes.


Subject(s)
Ambulatory Care/methods , Outpatients , Pulmonary Embolism/therapy , Acute Disease , Anticoagulants/therapeutic use , Cohort Studies , Female , Hemodynamics , Hemorrhage , Heparin, Low-Molecular-Weight/therapeutic use , Hospitalization , Humans , Male , Retrospective Studies , Safety
SELECTION OF CITATIONS
SEARCH DETAIL
...